Also trades as: 4519.T (JPX) · $vol 102M · CHGCY (OTC) · $vol 5M

$38.27

+0.43 (+1.13%)

Weekly Expected Move ±14.7%

$27 $33 $38 $44 $50

OTC · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 38 · $63.0B mcap · 615M float · 0.0013% daily turnover · Short 16% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$1.26T +7.6% ▲

5Y CAGR: +9.9%

Gross Profit

$895.0B +7.7% ▲

5Y CAGR: +11.8%

Operating Income

$590.7B +9.0% ▲

5Y CAGR: +14.4%

Net Income

$434.4B +12.2% ▲

5Y CAGR: +15.1%

EPS (Diluted)

$263.95 +12.1% ▲

5Y CAGR: +15.1%

EBITDA

$631.9B +10.2% ▲

5Y CAGR: +14.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$999.8B	$1.26T	$1.11T	$1.17T	$1.26T
YoY Growth	+27.0%	+26.0%	-11.8%	+5.3%	+7.6%
Cost of Revenue	$338.1B	$476.3B	$413.3B	$339.4B	$364.0B
Gross Profit	$661.6B	$783.7B	$698.1B	$831.2B	$895.0B
Gross Margin	66.2%	62.2%	62.8%	71.0%	71.1%
R&D Expenses	$137.3B	$149.6B	$174.9B	$181.4B	$187.8B
SG&A Expenses	$102.4B	$100.8B	$112.6B	$110.1B	$116.6B
Operating Expenses	$239.7B	$250.4B	$258.9B	$289.2B	$304.3B
Operating Income	$421.9B	$533.3B	$439.2B	$542.0B	$590.7B
Operating Margin	42.2%	42.3%	39.5%	46.3%	46.9%
Interest Expense	$48M	$61M	$0	-$1.0B	$1.0B
Income Before Tax	$419.4B	$531.2B	$443.8B	$543.0B	$598.3B
Tax Expense	$116.4B	$156.7B	$118.3B	$155.7B	$163.9B
Net Income	$303.0B	$374.4B	$325.5B	$387.3B	$434.4B
Net Margin	30.3%	29.7%	29.3%	33.1%	34.5%
EPS (Diluted)	$184.17	$227.57	$197.80	$235.36	$263.95
EBITDA	$450.3B	$564.7B	$470.9B	$573.7B	$631.9B
Shares Outstanding	1.65B	1.65B	1.65B	1.65B	1.65B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$315.7B	$302.1B	$288.5B	$290.0B	$337.9B	$346.6B	$323.8B	$339.1B
Cost of Revenue	$84.2B	$94.3B	$87.8B	$88.1B	$101.7B	$87.6B	$93.4B	$102.9B
Gross Profit	$231.5B	$207.8B	$200.6B	$201.9B	$236.3B	$259.0B	$230.4B	$236.2B
Gross Margin	73.3%	68.8%	69.6%	69.6%	69.9%	74.7%	71.2%	69.7%
R&D Expenses	$44.9B	$47.7B	$40.9B	$45.7B	$49.3B	$52.5B	$42.2B	$47.4B
SG&A Expenses	$27.8B	$32.4B	$23.2B	$28.4B	$5.3B	$37.0B	$24.6B	$28.8B
Operating Expenses	$71.1B	$86.7B	$64.0B	$74.3B	$54.6B	$89.4B	$66.7B	$76.8B
Operating Income	$160.4B	$121.1B	$136.7B	$127.7B	$181.7B	$169.6B	$163.7B	$159.4B
Operating Margin	50.8%	40.1%	47.4%	44.0%	53.8%	48.9%	50.6%	47.0%
Interest Expense	$0	$0	$0	$57M	$59M	$915M	$0	$0
Income Before Tax	$158.8B	$125.5B	$135.8B	$136.0B	$158.3B	$170.1B	$161.2B	$167.8B
Tax Expense	$49.3B	$33.9B	$38.6B	$38.8B	$45.5B	$41.5B	$45.1B	$52.3B
Net Income	$109.5B	$91.6B	$97.2B	$97.2B	$112.8B	$128.5B	$116.1B	$115.5B
Net Margin	34.7%	30.3%	33.7%	33.5%	33.4%	37.1%	35.9%	34.1%
EPS (Diluted)	$66.53	$55.62	$59.08	$59.04	$68.54	$78.09	$70.30	$69.42
EBITDA	$160.8B	$153.9B	$137.1B	$137.1B	$178.4B	$179.3B	$172.5B	$159.4B
Shares Outstanding	1.65B	1.65B	1.65B	1.65B	1.65B	1.65B	1.65B	1.65B

CHGCF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet